RE:Warrant extension implies 50-cents+ in two years
newdaydawning wrote: I believe that target is imminently doable if we accomplish just two things:
1. We get BTD for NMIBC supported by good outcomes from the US trials;
2 We get promising results from the early human trials showing TLD-1433's efficacy and safety for the treatment of - and protection against - Covid-19 and every other nasty virus.
Considering today's SP, a move to 50 cents minimum implies a return of 177% over 2 years!
IMO, the upside potential for TLT far outweighs the downside risk.
A one-two punch of a BTD plus promising Covid-19 results in early human trials should pique Pharma interest, moving us much higher than 50 cents imo.
Not only do I believe in the science (I.e. no downside risk, just uncertain upside potential), I also believe that our trials should pick up steam as the North American grip on Covid finally tightens later this year with rising immunity (both naturally & via vaccination). Also, as long as Canadian enrollment/treatment is able to remain steady, a BTD can be had before we see US data (or even enrollment).
In "two" years, if all goes as planned, we should be bought out in that time or at least a strong candidate for a buyout...& I will be bummed if we're still at $5.